Literature DB >> 7533383

FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.

J W Fay1, R A Nash, J R Wingard, D Przepiorka, R H Collins, C Anasetti, S M Devine, L A Piñeiro, R F Storb, R M Aro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7533383

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

3.  The effectiveness of tacrolimus and minidose methotrexate in the prevention of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in children: a single-center study in Korea.

Authors:  Seong Shik Park; So Eun Jun; Young Tak Lim
Journal:  Korean J Hematol       Date:  2012-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.